Patient Monitoring Device Maker Masimo Contemplates Separation of Consumer Business As Activist Investor Seeks Expanded Board Presence

Avatar photo







Activist Investor Pressures Masimo to Contemplate Consumer Business Separation

Activist Investor Pushes for Expanded Board Presence

On Monday, Quentin Koffey, the founder of Politan Capital Management, took a bold step by nominating two candidates for election to the Masimo Board of Directors at the upcoming 2024 Annual Meeting of Stockholders, as reported by the Wall Street Journal. The move signals the company’s potential entry into a proxy fight to secure two additional seats on the board of Masimo, currently valued at $7.1 billion.

Politan’s Growing Influence

Already holding two board seats, Politan Capital Management, with a substantial 9% stake in Masimo since 2022, seeks to reinforce its presence within the company. With a history of clinching board seats in the previous year’s annual meeting, including one for Koffey himself, Politan now eyes further expansion within Masimo’s six-person board.

Challenges and Strategic Shifts

Despite its success, Masimo faced a setback in 2022 post its acquisition of consumer-tech company Sound United, known for high-end audio equipment, for around $1 billion. This move drew skepticism from analysts and investors questioning its strategic alignment with the core business values. Masimo’s founder and CEO, Joe Kiani, defended the acquisition, highlighting its potential to penetrate retail channels, such as Best Buy.

Separation of Consumer Business

In a bid to refocus its business strategy, Masimo’s Board of Directors recently greenlit a proposal to evaluate the separation of its consumer business segment. This strategic shift will involve divesting its consumer audio and health products, including the Stork baby monitor and Freedom smartwatch and band, while retaining its focus on professional healthcare and telehealth products.

Impact on Profitability and Governance

Intending to enhance the profitability of its healthcare business, Masimo expects Joe Kiani to continue serving as Chairman and CEO, with plans to appoint him as Chairman of the newly formed entity post-separation. The company aims to execute the separation efficiently and promptly, although concerns have been raised by Politan regarding Masimo’s governance and its commitment to a seamless separation process.

Market Response

Following these recent developments, MASI shares experienced a significant surge of 13.7%, reaching $153.45 during after-hours trading on Friday, indicating investor confidence in the potential positive outcomes expected from Masimo’s strategic realignment.


The free Daily Market Overview 250k traders and investors are reading

Read Now